Losartan plays a fungistatic and fungicidal activity against candida albicans biofilms: drug repurposing for localized candidosis (2023)
- Authors:
- USP affiliated authors: LARA, VANESSA SOARES - FOB ; SILVA, RAFAELA ALVES DA - FOB ; SANTOS, CARLOS FERREIRA DOS - FOB
- Unidade: FOB
- DOI: 10.1089/adt.2023.013
- Subjects: CANDIDA ALBICANS; ESTOMATITE SOB PRÓTESE; PLACA BACTERIANA; FUNGICIDAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: New Rochelle
- Date published: 2023
- Source:
- Título: ASSAY and Drug Development Technologies
- ISSN: 1557-8127
- Volume/Número/Paginação/Ano: v. 21, n. 4, p. 157-165, June 2023
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
LARA, Vanessa Soares et al. Losartan plays a fungistatic and fungicidal activity against candida albicans biofilms: drug repurposing for localized candidosis. ASSAY and Drug Development Technologies, v. 21, n. 4, p. 157-165, 2023Tradução . . Disponível em: https://doi.org/10.1089/adt.2023.013. Acesso em: 01 abr. 2026. -
APA
Lara, V. S., Silva, R. A. da, Ferrari, T. P., Santos, C. F. dos, & Oliveira, S. H. P. de. (2023). Losartan plays a fungistatic and fungicidal activity against candida albicans biofilms: drug repurposing for localized candidosis. ASSAY and Drug Development Technologies, 21( 4), 157-165. doi:10.1089/adt.2023.013 -
NLM
Lara VS, Silva RA da, Ferrari TP, Santos CF dos, Oliveira SHP de. Losartan plays a fungistatic and fungicidal activity against candida albicans biofilms: drug repurposing for localized candidosis [Internet]. ASSAY and Drug Development Technologies. 2023 ; 21( 4): 157-165.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1089/adt.2023.013 -
Vancouver
Lara VS, Silva RA da, Ferrari TP, Santos CF dos, Oliveira SHP de. Losartan plays a fungistatic and fungicidal activity against candida albicans biofilms: drug repurposing for localized candidosis [Internet]. ASSAY and Drug Development Technologies. 2023 ; 21( 4): 157-165.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1089/adt.2023.013 - Corrigendum: Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease
- Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease
- Mast cells supernatant inhibit bone formation markers gene expression in SHR osteoblasts
- Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats
- Role of mast cell and RAS in mice periodontal tissue
- Telmisartan prevents alveolar bone loss by decreasing the expression of osteoclasts markers in hypertensive rats with periodontal disease
- Mast cells contribute to alveolar bone loss in Spontaneously Hypertensive Rats with periodontal disease regulating cytokines production
- Mast cells increase gene expression of osteoclastogenic markers in SHR
- Fitorerápicos associados a adesivo protético: atividade antimicrobiana contra Candida albicans
- Evaluation of roughness surface of heat acrylic resin immersed in antimicrobial natural products
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3152457.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
